Cite
HARVARD Citation
Gupta, N. et al. (2022). Safety and efficacy of sofosbuvir–velpatasvir–voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial. Lancet gastroenterology and hepatology. pp. 542-551. [Online].